Company Progenics Pharmaceuticals, Inc.
Equities
US7431871067
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 86,796,000 | 85,730,040 ( 98.77 %) | 200,000 ( 0.2304 %) | 98.77 % |
Company contact information
Progenics Pharmaceuticals, Inc.
One World Trade Center 47th floor
10007-0089, New York
+
http://www.progenics.comSector
1st Jan change | Capi. | |
---|---|---|
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.96% | 21.97B | |
-4.92% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |